Quantbot Technologies LP Mirum Pharmaceuticals, Inc. Transaction History
Quantbot Technologies LP
- $3.24 Billion
- Q3 2025
A detailed history of Quantbot Technologies LP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 448 shares of MIRM stock, worth $31,951. This represents 0.0% of its overall portfolio holdings.
Number of Shares
448Holding current value
$31,951% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
260Shares Held
56.7MCall Options Held
25.3KPut Options Held
98.9K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$485 Million18.24% of portfolio
-
Janus Henderson Group PLC London, X05.24MShares$373 Million0.14% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$231 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.76MShares$197 Million5.52% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$188 Million2.55% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $2.62B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...